Park Ha Biological Technology Co., Ltd.
BYAH
$1.05
$0.010.96%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -15.92% | -15.92% | 45.28% | 45.28% | 40.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.92% | -15.92% | 45.28% | 45.28% | 40.58% |
| Cost of Revenue | -13.58% | -13.58% | -40.33% | -40.33% | -47.74% |
| Gross Profit | -16.07% | -16.07% | 56.41% | 56.41% | 58.78% |
| SG&A Expenses | 659.71% | 659.71% | 3,148.79% | 3,148.79% | 86.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 591.03% | 591.03% | 2,655.04% | 2,655.04% | 42.25% |
| Operating Income | -732.08% | -732.08% | -21,437.23% | -21,437.23% | 38.67% |
| Income Before Tax | -732.25% | -732.25% | -21,191.20% | -21,191.20% | 38.93% |
| Income Tax Expenses | -62.35% | -62.35% | 303.15% | 303.15% | 78.13% |
| Earnings from Continuing Operations | -1,154.19% | -1,154.19% | -40,581.63% | -40,581.63% | 21.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,154.19% | -1,154.19% | -40,581.63% | -40,581.63% | 21.98% |
| EBIT | -732.08% | -732.08% | -21,437.23% | -21,437.23% | 38.67% |
| EBITDA | -708.78% | -708.78% | -19,115.44% | -19,115.44% | 38.19% |
| EPS Basic | -923.41% | -923.41% | -37,817.18% | -37,817.18% | 22.00% |
| Normalized Basic EPS | -593.99% | -593.99% | -19,694.00% | -19,694.00% | 38.92% |
| EPS Diluted | -923.85% | -923.85% | -37,817.18% | -37,817.18% | 22.07% |
| Normalized Diluted EPS | -593.99% | -593.99% | -19,694.00% | -19,694.00% | 38.92% |
| Average Basic Shares Outstanding | 28.00% | 28.00% | 7.54% | 7.54% | 0.00% |
| Average Diluted Shares Outstanding | 28.00% | 28.00% | 7.54% | 7.54% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |